• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Analysis of European Biosimilars Market Product Image

Analysis of European Biosimilars Market

  • ID: 2090208
  • December 2011
  • Region: Europe
  • 223 Pages
  • Frost & Sullivan

Impending Patent Expiries of Blockbuster Biologics Spells Good News for Biosimilars

The biosimilars manufacturing industry is at a nascent stage. However, the impending patent expiries of biologics are anticipated to result in the introduction of several new biosimilars and provide impetus to market development. “The expiration of patents and other intellectual property rights of biological innovators over the next decade opens up opportunities for biosimilars to enter the market and increase industry competition,” notes the analyst of this research. “Price reduction strategies will ensure increased adoption among physicians and patients alike, spurring market advancement.”

While the market offers lucrative growth prospects, the need for sizeable investments will pose a serious challenge to smaller firms. Complex production processes, expensive biological and chemical materials, and rigorous clinical trials as well as mandatory safety, efficacy and quality tests require significant investments. “The need for considerable financial outlays will hinder the entry of small biotech firms in particular,” cautions the analyst. “On the READ MORE >

Note: Product cover images may vary from those shown

1. Executive Summary
- 1.1 Executive Summary
- 1.2 Market Definitions
- 1.3 Market Segmentation
- 1.4 Geographic Segmentation
- 1.5 Executive Summary - Market Engineering Measurements
- 1.6 Executive Summary - CEO's Perspective

2. Total Biosimilars Market
- 2.1 Market Overview - Key Questions This Study Will Attempt to Answer
- 2.2 Market Overview
- 2.3 Total Biosimilars Market – Regional Overview
- 2.4 Forecasts and Trends – Global Biosimilars Market
- 2.5 Forecast Assumptions
- 2.6 Market Engineering Measurements
- 2.7 Total Biosimilars Market – Revenue Forecast
- 2.8 Market Share and Competitive Analysis- Total Biosimilars Market
- 2.9 Market Share – Companies (Global)

3. European Biosimilars Market
- 3.1 Market Overview – European Biosimilars

4. Industry Challenges
- 4.1 Key Industry Challenges

5. External Challenges: Drivers and Restraints- European Biosimilars Market
- 5.1 Drivers and Restraints
- 5.2 European Biosimilars Market – Impact Mapping of Drivers and Restraints

6. Forecast and Trends –European Biosimilars Market
- 6.1 Market Engineering Measurements
- 6.2 Europe Biosimilars Market -Revenue Forecast
- 6.3 Market Trends-European Biosimilars
- 6.4 European Biosimilars Market-Impact Assessment of Top Trends

7. Demand Analysis-European Biosimilars Market
- 7.1 European Biosimilars Market-Comparative Analysis: Generics, Biosimilars and Biologics
- 7.2 Biosimilars-Market Analysis
- 7.3 European Biosimilars Market- Biosimilar Pricing Analysis
- 7.4 European Biosimilars Market- PESTLE Analysis

8. Market Share and Competitive Analysis-European Biosimilars Market
- 8.1 Segment Breakdown Europe
- 8.2 European Biosimilars- Segment Market Share Analysis
- 8.3 European Biosimilars Companies Market Share Analysis
- 8.4 Competitive Environment
- 8.5 Competitive Landscape Analysis-European Biosimilars Companies
- 8.6 Competitive Landscape Analysis
- 8.7 Competitive Landscape Analysis-Biosimilars Characteristics

9. Regulatory Guidelines-European Biosimilars Market
- 9.1 Biosimilars Regulatory Guidelines

10. European Erythropoietin Biosimilars Market
- 10.1 Market Overview-European Erythropoietin Biosimilars

11. Forecast and Trends-European Erythropoietin Biosimilars Market
- 11. Market Engineering Measurements
- 11.2 European Erythropoietin Biosimilars Market-Revenue Forecast

12. Market Share and Competitive Analysis-European Erythropoietin Biosimilars Market
- 12.1 Erythropoietin Biosimilars-Market Analysis
- 12.2 Erythropoietin Biosimilars Market Share Analysis
- 12.3 Competitive Landscape-European Erythropoietin Biosimilars

13. Regulatory Guidelines-European Erythropoietin Biosimilars Market
- 13.1 EMEA Guidelines-Biosimilar Erythropoietin

14. European Granulocyte Colony Stimulating Factors Biosimilars Market
- 14.1 Market Overview-European Granulocyte Colony Stimulating Factors Biosimilars

15. Forecast and Trends-European Granulocyte Colony Stimulating Factors Biosimilars Market
- 15.1 Market Engineering Measurements
- 15.2 Granulocyte Colony Stimulating Factor Biosimilars Market-Revenue Forecast

16. Market Share and Competitive Analysis-European Granulocyte Colony Stimulating Factors Biosimilars Market
- 16.1 Granulocyte Colony Stimulating Factors Biosimilars Market Analysis
- 16.2 Granulocyte Colony Stimulating Factors Biosimilars Market Share Analysis
- 16.3 Competitive Landscape-European Granulocyte Colony Stimulating Factors Biosimilars

17. Regulatory Guidelines-European Granulocyte Colony Stimulating Factors Biosimilars Market
- 17.1 EMEA Guidelines-Biosimilar Granulocyte Colony Stimulating Factors

18. European Human Growth Hormone Biosimilars Market
- 18.1 Market Overview-European Human Growth Hormone Biosimilars

19. Forecast and Trends-European Human Growth Hormone Biosimilars Market
- 19.1 Market Engineering Measurements
- 19.2 Human Growth Hormone Biosimilars Market-Revenue Forecast

20. Market Share and Competitive Analysis-European Human Growth Hormone Biosimilars Market
- 20.1 Human Growth Hormone Biosimilars-Market Analysis
- 20.2 Competitive Landscape-European Human Growth Hormone Biosimilars

21. Regulatory Guidelines-European Human Growth Hormone Biosimilars Market
- 21.1 EMEA Guidelines-Biosimilar Human Growth Hormone

22. Key Emerging Biosimilars in Europe: Monoclonal Antibodies
- 22.1 Market Overview-European Monoclonal Antibodies Biosimilars

23. Market Analysis-European Monoclonal Antibodies Biosimilars Market
- 23.1 Monoclonal Antibodies Biosimilars- Market Analysis

24. Regulatory Guidelines-European Monoclonal Antibodies Biosimilars Market
- 24.1 EMEA Guidelines-Biosimilar Monoclonal Antibodies

25. Key Emerging Biosimilars in Europe: Insulin
- 25.1 Market Overview-European Insulin Biosimilars

26. Market Analysis-European Insulin Biosimilars Market
- 26.1 Insulin Biosimilars-Market Analysis

27. Regulatory Guidelines-European Insulin Biosimilars Market
- 27.1 EMEA Guidelines-Biosimilar Insulin

28. Key Emerging Biosimilars in Europe: Interferon
- 28.1 Market Overview-European Interferon Biosimilars

29. Market Analysis-European Interferon Biosimilars Market
- 29.1 Interferon Biosimilars-Market Analysis

30. Regulatory Guidelines-European Interferon Biosimilars Market
- 30.1 EMEA Guidelines-Biosimilar Interferon

31. Regional Analysis of European Biosimilars Market-The United Kingdom
- 31.1 Biosimilars Market Overview-The United Kingdom

32. Forecast and Trends-The United Kingdom Biosimilars Market
- 32.1 Market Engineering Measurements
- 32.2 The United Kingdom Biosimilars Market-Revenue Forecast

33. Biosimilars Market-Germany
- 33.1 Biosimilars Market Overview-Germany

34. Forecast and Trends-Germany Biosimilars Market
- 34.1 Market Engineering Measurements
- 34.2 Germany Biosimilars Market-Revenue Forecast

35. Regional Analysis of European Biosimilars Market-France
- 35.1 Biosimilars Market Overview-France

36. Forecast and Trends-France Biosimilars Market
- 36.1 Market Engineering Measurements
- 36.2 French Biosimilars Market-Revenue Forecast

37. Regional Analysis of European Biosimilars Market- Italy
- 37.1 Biosimilars Market Overview-Italy

38. Forecast and Trends-Italy Biosimilars Market
- 38.1 Market Engineering Measurements
- 38.2 Italian Biosimilars Market-Revenue Forecast

39. Regional Analysis of European Biosimilars Market- Spain
- 39.1 Biosimilars Market Overview- Spain

40. Forecast and Trends- Spain Biosimilars Market
- 40.1 Market Engineering Measurements
- 40.2 Spanish Biosimilars Market-Revenue Forecast

41. Regional Analysis of European Biosimilars Market- Benelux
- 41.1 Biosimilars Market Overview- Benelux

42. Forecast and Trends- Benelux Biosimilars Market
- 42.1 Market Engineering Measurements
- 42.2 Benelux Biosimilars Market-Revenue Forecast

43. Regional Analysis of European Biosimilars Market- Scandinavia
- 43.1 Biosimilars Market Overview- Scandinavia

44. Forecast and Trends- Scandinavia Biosimilars Market
- 44.1 Market Engineering Measurements
- 44.2 Scandinavian Biosimilars Market-Revenue Forecast

45. Product Profiling
- 45.1 Product Profiling-Biosimilars in Europe
- 45.2 Product Profiling-Biologics
- 45.3 Future Landscape Analysis

46. Conclusions and Strategic Recommendations
- 46.1 Biosimilars Market – Key Success Factors
- 46.2 Biosimilars Market – Manufacturing Strategies
- 46.3 Biosimilars Market – Commercialisation Strategies
- 46.4 Conclusions

47. The Last Word

48. Appendix
- 48.1 Biotech Companies
- 48.2 Government R&D Expenditure in Biotechnology
- 48.3 Pharmaceutical R&D Expenditure
- 48.4 Pharmaceutical R&D Expenditure as a Percentage of Pharmaceutical Market
- 48.5 Government Healthcare Expenditure
- 48.6 Abbreviations

49. Market Engineering Methodology

List of Tables:

Biosimilars Market: Manufacturing and Development Process for Generics, Biosimilars and Biologics (Europe), 2010
Total Biosimilars Market: Company Market Share Analysis of Top 4 Participants (Global), 2010
Biosimilars Market: Time from Marketing Authorisation to Price Approval (Europe), 2010
Biosimilars Market: Market Share Analysis of Segments (Europe), 2010
Biosimilars Market: Company Market Share Analysis of Market Participants (Europe), 2010
Biosimilars Market: Competitive Structure (Europe), 2010
Erythropoietin Biosimilars Market: Retail Analysis (Europe), 2010
Erythropoietin Biosimilars Market: Company Market Share Analysis of Market Participants (Europe), 2010
Granulocyte Colony Stimulating Factor Biosimilars Market: Company Market Share Analysis of Market Participants (Europe), 2010
Decision Support Database: Biotech Companies (Western Europe), 2002-2012
Decision Support Database: Government R&D Expenditure in Biotechnology (Western Europe), 2002-2012
Decision Support Database: Pharmaceutical R&D Expenditure (Western Europe), 2002-2012
Decision Support Database: Pharmaceutical R&D Expenditure as a Percentage of Pharmaceutical Market (Western Europe), 2002-2012
Decision Support Database: Government Healthcare Expenditure (Western Europe), 2002-2012
Biosimilars Market: Market Segmentation (Europe), 2010
Biosimilars Market: Geographic Segmentation (Europe), 2010
Biosimilars Market: Market Engineering Measurements (Europe), 2010
Total Biosimilars Market: Market Share Percent by Country (Global), 2010
Total Biosimilars Market: Market Engineering Measurements (Global), 2010
Total Biosimilars Market: Revenue Forecast (Global), 2008-2017
Total Biosimilars Market: Company Market Share by Revenues (Global), 2010
Biosimilars Market: Key Stake Holders (Europe), 2010
Biosimilars Market: Key Industry Challenges (Europe), 2011-2017
Biosimilars Market: Key Market Drivers and Restraints (Europe), 2011-2017
European Biosimilars Market: Impact Mapping of Drivers and Restraints (Europe), 2011-2017
Biosimilars Market: Market Engineering Measurements (Europe), 2010
Biosimilars Market: Revenue Forecast (Europe), 2008-2017
Biosimilars Market: Impact Assessment of Top Trends (Europe), 2010
Biosimilars Market: Pricing Analysis (Europe), 2010
Biosimilars Market: PESTLE Analysis (Europe), 2010
Biosimilars Market: Market Share Percent by Segment (Europe), 2010
Biosimilars Market: Company Market Share by Revenues (Europe), 2010
Erythropoietin Biosimilars Market: Market Engineering Measurements (Europe), 2010
Erythropoietin Biosimilars Market: Revenue Forecast (Europe), 2008-2017
Granulocyte Colony Stimulating Factors Biosimilars Market: Market Engineering Measurements (Europe), 2010
Granulocyte Colony Stimulating Biosimilars Market: Revenue Forecast (Europe), 2008-2017
Granulocyte Colony Stimulating Biosimilars Market: Market Share Percent by Companies (Europe), 2010
Human Growth Hormone Biosimilars Market: Market Engineering Measurements (Europe), 2010
Human Growth Hormone Biosimilars Market: Revenue Forecast (Europe), 2008-2017
Biosimilars Market: Market Engineering Measurements (The United Kingdom), 2010
Biosimilars Market: Revenue Forecast (The United Kingdom), 2008-2017
Biosimilars Market: Market Engineering Measurements (Germany), 2010
Biosimilars Market: Revenue Forecast (Germany), 2008-2017
Biosimilars Market: Market Engineering Measurements (France), 2010
Biosimilars Market: Revenue Forecast (France), 2008-2017
Biosimilars Market: Market Engineering Measurements (Italy), 2010
Biosimilars Market: Revenue Forecast (Italy), 2008-2017
Biosimilars Market: Market Engineering Measurements (Spain), 2010
Biosimilars Market: Revenue Forecast (Spain), 2008-2017
Biosimilars Market: Market Engineering Measurements (Benelux), 2010
Biosimilars Market: Revenue Forecast (Benelux), 2008-2017
Biosimilars Market: Market Engineering Measurements (Scandinavia), 2010
Biosimilars Market: Revenue Forecast (Scandinavia), 2008-2017

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos